Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Liver Diseases

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 53 articles:
HTML format



Single Articles


    March 2008
  1. NUZZO C , Zeuli M, Ferraresi V, Ciccarese M, et al
    Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  2. SUWA D , Konno H, Tanaka T, Urano T, et al
    Intraperitoneal infusion of recombinant plasminogen activator inhibitor type 2 induced apoptosis in implanted human colon cancer and inhibited its growth and liver metastasis.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  3. TACHIMORI A , Yamada N, Amano R, Ohira M, et al
    Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


    January 2008
  4. SAMESHIMA S , Tomozawa S, Horikoshi H, Motegi K, et al
    5-Fluorouracil-related gene expression in hepatic artery infusion-treated patients with hepatic metastases from colorectal carcinomas.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  5. OKAMURA M , Shimada J, Sakagami H
    Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  6. SHIBA H , Misawa T, Iida T, Okamoto T, et al
    Adenovirus vector-mediated gene therapy using iodized oil esters for hepatocellular carcinoma in rats.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  7. DIVELLA R , Lacalamita R, Tommasi S, Coviello M, et al
    PAI-1, t-PA and circulating hTERT DNA as related to virus infection in liver carcinogenesis.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


  8. HOEFIG KP , Thorns C, Roehle A, Kaehler C, et al
    Unlocking pathology archives for microRNA-profiling.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available


    November 2007
  9. INTARAPRASONG P , Assi K, Owen DA, Huntsman DG, et al
    Expression of integrin-linked kinase is not a useful prognostic marker in resected hepatocellular cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  10. GIORGIO A , De Stefano G, Coppola C, Ferraioli G, et al
    Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  11. VITALE FV , Romeo P, Vasta F, Panebianco V, et al
    Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  12. JIANG C , Zhou B, Fan K, Heung E, et al
    A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45beta expression in hepatocellular carcinoma cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  13. GOEKKURT E , Stoehlmacher J, Stueber C, Wolschke C, et al
    Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    September 2007
  14. SHIMAKAWA T , Naritaka Y, Asaka S, Isohata N, et al
    Surgical treatment for superficial esophageal cancer with liver cirrhosis and esophageal varices: report of a case.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  15. UCHIMURA S , Iizuka N, Tamesa T, Miyamoto T, et al
    Resampling based on geographic patterns of hepatitis virus infection reveals a common gene signature for early intrahepatic recurrence of hepatocellular carcinoma.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  16. FUJITA S , Yamamoto S, Akasu T, Moriya Y, et al
    Quantification of CD10 mRNA in colorectal cancer and relationship between mRNA expression and liver metastasis.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    July 2007
  17. HOLDENRIEDER S , Eichhorn P, Beuers U, Samtleben W, et al
    Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  18. QU XJ , Cui SX, Tian Z, Li X, et al
    Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  19. HSU SC , Kuo CL, Lin JP, Lee JH, et al
    Crude extracts of Euchresta formosana radix induce cytotoxicity and apoptosis in human hepatocellular carcinoma cell line (Hep3B).
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  20. HSU SC , Kuo CL, Lin JP, Lee JH, et al
    Crude extracts of Euchresta formosana radix inhibit invasion and migration of human hepatocellular carcinoma cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  21. YAMADA S , Nomoto S, Fujii T, Takeda S, et al
    Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  22. MAMBRINI A , Guglielmi A, Pacetti P, Iacono C, et al
    Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  23. KAIBORI M , Matsui Y, Saito T, Kamiyama Y, et al
    Risk factors for different patterns of recurrence after resection of hepatocellular carcinoma.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  24. POGGI G , Riccardi A, Quaretti P, Teragni C, et al
    Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  25. LISKA V , Holubec L Jr, Treska V, Skalicky T, et al
    Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  26. CHAN LS , Malcontenti-Wilson C, Muralidharan V, Christophi C, et al
    Effect of vascular targeting agent Oxi4503 on tumor cell kinetics in a mouse model of colorectal liver metastasis.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  27. TSUBOI K , Shimura T, Masuda N, Ide M, et al
    Galectin-3 expression in colorectal cancer: relation to invasion and metastasis.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  28. FRIEDRICH RE , Klapdor R, Bartel-Friedrich S
    Rapidly progressive and metastatic mucoepidermoid carcinoma: application of serological tumor markers.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  29. SCHWARTE S , Brabant EG, Bastian L, Bruns F, et al
    Cortisol as a possible marker of metastatic adrenocortical carcinoma: a case report with 3-year follow-up.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  30. LISKA V , Holubec L, Treska V, Skalicky T, et al
    Tumor markers as useful predictors of survival rate after exploratory laparotomy for liver malignancies.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    May 2007
  31. CHEN XC , Yu B, Dong JC, Gu YX, et al
    A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML) for patients with hepatic malignancies.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  32. HSIEH YJ , Liu RS, Hwu L, Ke CC, et al
    Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    March 2007
  33. CAPORALE A , Brescia A, Galati G, Castelli M, et al
    Locoregional IL-2 therapy in the treatment of colon cancer. Cell-induced lesions of a murine model.
    Anticancer Res. 2007;27:985-9.
    PubMed     Related articles    Abstract available


  34. HANDAYANI T , Sakinah S, Nallappan M, Pihie AH, et al
    Regulation of p53-, Bcl-2- and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells.
    Anticancer Res. 2007;27:965-71.
    PubMed     Related articles    Abstract available


  35. KOBEITER H , Georgiades CS, Leakakos T, Torbenson M, et al
    Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field.
    Anticancer Res. 2007;27:755-60.
    PubMed     Related articles    Abstract available


    January 2007
  36. ZHENG H , Tsuneyama K, Cheng C, Takahashi H, et al
    Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


  37. KAWAMURA K , Yu L, Tomizawa M, Shimozato O, et al
    Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available


    November 2006
  38. UEDA Y , Yabe K, Taira Z
    A bio-defensive function induced by low-dose lipopolysaccharide pre-treatment against CCl4-induced fulminant hepatic failure in rats.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  39. PASETTO LM , Merenda R, Pilati P, Sinigaglia G, et al
    Hepatic metastases of colorectal cancer: locoregional intra-arterial treatment.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  40. IIZUKA N , Sakaida I, Moribe T, Fujita N, et al
    Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  41. TAKAHASHI S , Kuroki Y, Nasu K, Nawano S, et al
    Positron emission tomography with F-18 fluorodeoxyglucose in evaluating colorectal hepatic metastasis down-staged by chemotherapy.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  42. GOTOHDA N , Ishii H, Konishi M, Nakagohri T, et al
    Selection criteria for reduction hepatectomy in multiple advanced hepatocellular carcinoma.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  43. ASTNER ST , Pihusch R, Nieder C, Rachinger W, et al
    Extensive local and systemic therapy in extraneural metastasized glioblastoma multiforme.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


    September 2006
  44. SISTAYANARAIN A , Tsuneyama K, Zheng H, Takahashi H, et al
    Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  45. EL-ANEED A , Banoub J
    Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  46. POHLEN U , Rieger H, Mansmann U, Berger G, et al
    Hepatic arterial infusion (HAI). Comparison of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres versus 5-fluorouracil and folinic acid in patients with non-resectable colorectal liver metastases.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  47. HSU LM , Huang YS, Yang SY, Chang FY, et al
    Polymorphism of T-cell receptor gamma short tandem repeats as a susceptibility risk factor of hepatocellular carcinoma.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  48. KAIBORI M , Tanigawa N, Matsui Y, Saito T, et al
    Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  49. MIYAGAWA K , Sakakura C, Nakashima S, Yoshikawa T, et al
    Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  50. CORDOBA-PEDREGOSA MDEL C , Villalba JM, Gonzalez-Aragon D, Bello RI, et al
    Cellular density and cell type are the key factors in growth inhibition induced by 2,5bis [1-aziridinyl]-1,4 benzoquinone (DZQ).
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  51. AMOH Y , Nagakura C, Maitra A, Moossa AR, et al
    Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  52. ALIBERTI C , Tilli M, Benea G, Fiorentini G, et al
    Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


  53. MARTONI AA , Bernardi A, Quercia S
    Trastuzumab plus estrogen suppression as salvage treatment in a case of liver failure due to metastatic breast cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: